Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

ID4 promotes AR expression and blocks tumorigenicity of PC3 prostate cancer cells

Journal Article · · Biochemical and Biophysical Research Communications
Deregulation of tumor suppressor genes is associated with tumorigenesis and the development of cancer. In prostate cancer, ID4 is epigenetically silenced and acts as a tumor suppressor. In normal prostate epithelial cells, ID4 collaborates with androgen receptor (AR) and p53 to exert its tumor suppressor activity. Previous studies have shown that ID4 promotes tumor suppressive function of AR whereas loss of ID4 results in tumor promoter activity of AR. Previous study from our lab showed that ectopic ID4 expression in DU145 attenuates proliferation and promotes AR expression suggesting that ID4 dependent AR activity is tumor suppressive. In this study, we examined the effect of ectopic expression of ID4 on highly malignant prostate cancer cell, PC3. Here we show that stable overexpression of ID4 in PC3 cells leads to increased apoptosis and decreased cell proliferation and migration. In addition, in vivo studies showed a decrease in tumor size and volume of ID4 overexpressing PC3 cells, in nude mice. At the molecular level, these changes were associated with increased androgen receptor (AR), p21, and AR dependent FKBP51 expression. At the mechanistic level, ID4 may regulate the expression or function of AR through specific but yet unknown AR co-regulators that may determine the final outcome of AR function. - Highlights: • ID4 expression induces AR expression in PC3 cells, which generally lack AR. • ID4 expression increased apoptosis and decreased cell proliferation and invasion. • Overexpression of ID4 reduces tumor growth of subcutaneous xenografts in vivo. • ID4 induces p21 and FKBP51 expression- co-factors of AR tumor suppressor activity.
OSTI ID:
22606205
Journal Information:
Biochemical and Biophysical Research Communications, Journal Name: Biochemical and Biophysical Research Communications Journal Issue: 1 Vol. 478; ISSN BBRCA9; ISSN 0006-291X
Country of Publication:
United States
Language:
English

Similar Records

A role for SIRT1 in cell growth and chemoresistance in prostate cancer PC3 and DU145 cells
Journal Article · Fri Aug 29 00:00:00 EDT 2008 · Biochemical and Biophysical Research Communications · OSTI ID:21143835

Syndecan-1 responsive microRNA-126 and 149 regulate cell proliferation in prostate cancer
Journal Article · Thu Jan 01 23:00:00 EST 2015 · Biochemical and Biophysical Research Communications · OSTI ID:22416873

Increased expression of bHLH transcription factor E2A (TCF3) in prostate cancer promotes proliferation and confers resistance to doxorubicin induced apoptosis
Journal Article · Fri May 25 00:00:00 EDT 2012 · Biochemical and Biophysical Research Communications · OSTI ID:22207868